# Plasmonic Photothermal and Stem Cell Therapy of Atherosclerosis Versus Stenting

> **NCT01436123** · PHASE1 · TERMINATED · sponsor: **Ural State Medical University** · enrollment: 62 (actual)

## Conditions studied

- Coronary Artery Disease
- Atherosclerosis

## Interventions

- **OTHER:** Stenting and micro-infusion of NP
- **DEVICE:** Implantation of everolimus-eluting stent

## Key facts

- **NCT ID:** NCT01436123
- **Lead sponsor:** Ural State Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-12
- **Primary completion:** 2012-07
- **Final completion:** 2012-10
- **Target enrollment:** 62 (ACTUAL)
- **Why stopped:** The study was terminated under the political pressure of the Federal Security Service of the Russian Federation (FSB) and the Russian Society of Cardiology
- **Last updated:** 2015-05-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01436123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01436123, "Plasmonic Photothermal and Stem Cell Therapy of Atherosclerosis Versus Stenting". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01436123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*